FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Lifts Hold on Cialis Rx-to-OTC Study

FDA removes clinical hold on a Sanofi actual use trial to support its planned Rx-to-OTC switch for Cialis (tadalafil), which it licensed from Eli Lill...

latest-news-card-1
Human Drugs

Woodcock Joins Friends of Cancer Research Board

Patient advocacy group Friends of Cancer Research adds former principal deputy commissioner Janet Woodcock to their board of directors.

latest-news-card-1
Human Drugs

FDA Fast Track for Heart Imaging Agent

FDA grants Life Molecular Imaging a fast track designation to [18F]florbetaben for diagnosing cardiac amyloid light-chain and amyloid transthyretin-re...

latest-news-card-1
Human Drugs

Atara, FDA Agree on Steps to Lift Clinical Holds

Atara Biotherapeutics says it has reached an agreement with FDA on the steps needed to lift agency clinical holds on its Ebvallo and ATA3219.

latest-news-card-1
Medical Devices

Inflammatix Sepsis Molecular Diagnostic Cleared

FDA clears an Inflammatix 510(k) for its TriVerity Test System, which it describes as a first-in-class molecular test for patients with suspected acut...

latest-news-card-1
Human Drugs

Multiple Incell Violations Cited

FDA warns San Antonio, TX-based Incell Corp. about CGMP and other issues in its work as a contract manufacturer of a product derived from amniotic flu...

latest-news-card-1
Human Drugs

Amended Sanofi Warning Letter

FDA issues an amended Warning Letter to Sanofis Genzyme unit in Framingham, MA, about CGMP deviations in its manufacturing of active pharmaceutical in...

latest-news-card-1
Human Drugs

J&J Wins Monotherapy Use for Spravato

FDA approves a Johnson & Johnson supplemental NDA for Spravato (esketamine) nasal spray for monotherapy use in treating major depressive disorder in a...

Human Drugs

Biomarker Bioanalytical Method Validation

FDA publishes a guidance on a bioanalytical method to validate biomarkers in drug and biological product applications.

latest-news-card-1
Human Drugs

7 Observations on SCA Pharmaceuticals FDA-483

FDA releases the form FDA-483 with seven observations from an inspection at the Windsor, CT-based SCA Pharmaceuticals outsourcing facility.